How big is the Pneumococcal Vaccines Market?

The Pneumococcal Vaccines Market size is expected to reach USD 8.80 billion in 2024 and grow at a CAGR of 4.83% to reach USD 11.20 billion by 2029. Read More

What is the current Pneumococcal Vaccines Market size?

In 2024, the Pneumococcal Vaccines Market size is expected to reach USD 8.80 billion. Read More

Who are the key players in Pneumococcal Vaccines Market?

Pfizer Inc., CSL Ltd., Serum Institute of India Pvt. Ltd., GSK plc and Merck KGaA are the major companies operating in the Pneumococcal Vaccines Market. Read More

Which is the fastest growing region in Pneumococcal Vaccines Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Pneumococcal Vaccines Market?

In 2024, the North America accounts for the largest market share in Pneumococcal Vaccines Market. Read More

What years does this Pneumococcal Vaccines Market cover, and what was the market size in 2023?

In 2023, the Pneumococcal Vaccines Market size was estimated at USD 8.37 billion. The report covers the Pneumococcal Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Pneumococcal Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Pneumococcal Vaccines Market Share

Statistics for the 2023 & 2024 Pneumococcal Vaccines market share, created by Mordor Intelligence™ Industry Reports. Pneumococcal Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Pneumococcal Vaccines Industry

The pneumococcal vaccine market is highly consolidated and consists of a few players. Market players adopt various strategies to expand their business, such as acquisitions, collaborations, and product launches. Companies expand their presence in other geographies by collaborating with distributors and thus increase product availability, boosting market growth. Some companies currently dominating the market are GSK PLC, Pfizer Inc., CSL Ltd, Merck KGaA, Serum Institute of India Pvt. Ltd, and Sanofi.